The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.

A drug used to treat certain types of HER2-negative breast cancer that have spread to other parts of the body. It is used in patients with certain mutations (changes) in the BRCA1 or BRCA2 genes who have already been treated with other anticancer drugs. It is also used to treat recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer that has gotten better after treatment with anticancer drugs that included platinum. AZD2281 is also used to treat certain types of advanced ovarian, fallopian tube, or primary peritoneal cancer. It is used in patients with certain mutations in the BRCA1 or BRCA2 genes who have already been treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. AZD2281 blocks an enzyme involved in many cell functions, including the repair of DNA damage. Blocking this enzyme may help keep cancer cells from repairing their damaged DNA, causing them to die. AZD2281 is a type of poly (ADP-ribose) polymerase inhibitor. Also called Lynparza, olaparib, and PARP inhibitor AZD2281.